Vulnerability Description
Cross-site scripting (XSS) vulnerability in the Quick Stats page (psilan.cgi) in ZTE ZXDSL 831 and 831CII allows remote attackers to inject arbitrary web script or HTML via the domainname parameter in a save action. NOTE: this issue was SPLIT from CVE-2014-9021 per ADT1 due to different affected products and codebases.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Zte | Zxdsl 831 | - |
| Zte | Zxdsl 831Cii | - |
Related Weaknesses (CWE)
References
- http://packetstormsecurity.com/files/129016/ZTE-831CII-Hardcoded-Credential-XSS-Exploit
- http://packetstormsecurity.com/files/129017/ZTE-ZXDSL-831-Cross-Site-Scripting.hExploit
- http://www.securityfocus.com/archive/1/533930/100/0/threaded
- http://www.securityfocus.com/archive/1/533931/100/0/threaded
- http://www.securityfocus.com/bid/70984
- http://www.securityfocus.com/bid/70985
- https://exchange.xforce.ibmcloud.com/vulnerabilities/98584
- http://packetstormsecurity.com/files/129016/ZTE-831CII-Hardcoded-Credential-XSS-Exploit
- http://packetstormsecurity.com/files/129017/ZTE-ZXDSL-831-Cross-Site-Scripting.hExploit
- http://www.securityfocus.com/archive/1/533930/100/0/threaded
- http://www.securityfocus.com/archive/1/533931/100/0/threaded
- http://www.securityfocus.com/bid/70984
- http://www.securityfocus.com/bid/70985
- https://exchange.xforce.ibmcloud.com/vulnerabilities/98584
FAQ
What is CVE-2014-9020?
CVE-2014-9020 is a vulnerability with a CVSS score of 4.3 (MEDIUM). Cross-site scripting (XSS) vulnerability in the Quick Stats page (psilan.cgi) in ZTE ZXDSL 831 and 831CII allows remote attackers to inject arbitrary web script or HTML via the domainname parameter in...
How severe is CVE-2014-9020?
CVE-2014-9020 has been rated MEDIUM with a CVSS base score of 4.3/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2014-9020?
Check the references section above for vendor advisories and patch information. Affected products include: Zte Zxdsl 831, Zte Zxdsl 831Cii.